Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma

Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma

Pancreatic adenocarcinoma is one of the most lethal diseases with a 5-year survival rate of about 8%. ASXL2 is an epigenetic regulator associated with various tumors including colorectal cancer, breast cancer, and myeloid leukemia. However, the role of ASXL2 in pancreatic cancer remains unclear. Thi...

Full description

Bibliographic Details
Main Authors: Gaoming Wang, Ludi Yang, Jinli Gao, Huiling Mu, Yanxiang Song, Xiaohua Jiang, Bo Chen, Ran Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
ASXL2
prognosis
immunotherapy
pancreatic cancer
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.736694/full

Similar Items

Similar Items